The actual death rate for the trial cohort is close to 2%: Pfizer said 0.8 percent of patients who got the drug combination within three days were hospitalized

The actual death rate for the trial cohort is close to 2%: Pfizer said 0.8 percent of patients who got the drug combination within three days were hospitalized within four weeks — three out of 389 patients — compared to 7 percent of patients who got placebos, or 27 out of 385. And seven of those who got placebos died, Pfizer said. No one who got the treatment died within a month. https://nymag.com/intelligencer/2021/11/pfizers-new-covid-pill-appears-to-be-a-huge-deal.html https://nymag.com/intelligencer/2021/11/pfizers-new-covid-pi...